AB
DNLI icon

Amalgamated Bank’s Denali Therapeutics DNLI Stock Holding History

Amalgamated Bank’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,161
Closed -$69K – 1959
2025
Q4 		$69K Sell
4,161
-144
-3% -$2.43K ﹤0.01% 1758
2025
Q3 		$63K Hold
4,305
– – ﹤0.01% 1775
2025
Q2 		$60K Hold
4,305
– – ﹤0.01% 1791
2025
Q1 		$59K Buy
4,305
+113
+3% +$2.17K ﹤0.01% 1766
2024
Q4 		$85K Hold
4,192
– – ﹤0.01% 1736
2024
Q3 		$122K Hold
4,192
– – ﹤0.01% 1673
2024
Q2 		$97K Buy
4,192
+168
+4% +$3.23K ﹤0.01% 1719
2024
Q1 		$83K Sell
4,024
-13,033
-76% -$245K ﹤0.01% 1757
2023
Q4 		$366K Sell
17,057
-1,198
-7% -$23.7K ﹤0.01% 1562
2023
Q3 		$377K Buy
18,255
+679
+4% +$17.2K ﹤0.01% 1545
2023
Q2 		$519K Buy
17,576
+2,196
+14% +$61.7K ﹤0.01% 1419
2023
Q1 		$354K Sell
15,380
-2,579
-14% -$71K ﹤0.01% 1571
2022
Q4 		$499K Buy
17,959
+2,017
+13% +$60K ﹤0.01% 1465
2022
Q3 		$489K Buy
15,942
+380
+2% +$12.4K ﹤0.01% 1445
2022
Q2 		$458K Buy
15,562
+669
+4% +$17.5K ﹤0.01% 1504
2022
Q1 		$479K Sell
14,893
-1,119
-7% -$38.5K ﹤0.01% 1561
2021
Q4 		$714K Sell
16,012
-172
-1% -$8.15K 0.01% 1400
2021
Q3 		$816K Sell
16,184
-997
-6% -$56.2K 0.01% 1348
2021
Q2 		$1.35M Buy
17,181
+8,228
+92% +$509K 0.01% 1139
2021
Q1 		$511K Sell
8,953
-875
-9% -$58.6K 0.02% 965
2020
Q4 		$823K Buy
9,828
+49
+0.5% +$2.96K 0.03% 667
2020
Q3 		$350K Sell
9,779
-285
-3% -$8.58K 0.02% 1032
2020
Q2 		$243K Buy
+10,064
New +$237K 0.01% 1218

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's DNLI Position: Q1 2026 in Review

Amalgamated Bank sold out of Denali Therapeutics (DNLI) in Q1 2026, closing a stake of 4,161 shares — an estimated $69K sold.

Amalgamated Bank first reported a position in DNLI in Q2 2020 and held it in 23 quarters. The position peaked at $1.35M in Q2 2021. 269 funds tracked by Wall St. Rank hold DNLI as of Q1 2026.

  • Amalgamated Bank reported no remaining Denali Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 4,161 Denali Therapeutics shares in Q1 2026, an estimated $69K.
  • Amalgamated Bank first reported a position in Denali Therapeutics in Q2 2020 and held it in 23 quarters.
  • Amalgamated Bank's Denali Therapeutics position peaked at $1.35M in Q2 2021.
  • 269 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.